IsoPlexis Corporation IPO Advisory
Share this IPO Profile:Smart Search
For IPO Boutique's "scale of 1 to 5" BUY rating on IsoPlexis Corporation, and our comprehensive analysis, click "Buy Market Research".
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| IsoPlexis Corporation | ISO - NASDAQ |
$14.00-$16.00 | $15.00 | $14.75 | 8.33 million | 10/8/2021 |
| Morgan Stanley, Cowen, Evercore, SVB Leerink | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-07-20 Terms Added 2021-10-01 | ||||||
IsoPlexis Corporation Quote & Chart - Click for current quote - ISO
IPO Boutique aggregates information on public companies and private companies, such as "ISO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About IsoPlexis Corporation (adapted from IsoPlexis Corporation prospectus):
They are enabling deeper access to in vivo biology and driving durable and potentially transformational research on disease in a new era of advanced medicine.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are enabling deeper access to in vivo biology and driving durable and potentially transformational research on disease in a new era of advanced medicine.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "ISO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.